These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20073283)

  • 41. The epidemiology of new HIV infections and interventions to limit HIV transmission.
    Buchbinder S
    Top HIV Med; 2009; 17(2):37-43. PubMed ID: 19401606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re.: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
    Berger RE
    J Urol; 2011 May; 185(5):1729. PubMed ID: 22088702
    [No Abstract]   [Full Text] [Related]  

  • 43. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).
    Carballo-Diéguez A; Balán IC; Morrow K; Rosen R; Mantell JE; Gai F; Hoffman S; Maslankowski L; El-Sadr W; Mayer K
    AIDS Care; 2007 Sep; 19(8):1026-31. PubMed ID: 17852000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of a breath test for monitoring adherence to vaginal administration of antiretroviral microbicide gels.
    Morey TE; Wasdo S; Wishin J; Quinn B; van der Straten A; Booth M; Gonzalez D; Derendorf H; Melker RJ; Dennis DM
    J Clin Pharmacol; 2013 Jan; 53(1):103-11. PubMed ID: 23400750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling interventions to assess HIV epidemic impact in Africa.
    Vermund SH
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):121-4. PubMed ID: 21857360
    [No Abstract]   [Full Text] [Related]  

  • 47. Pre-exposure prophylaxis in women fails to prevent HIV infection in African study.
    Mayor S
    BMJ; 2015 Feb; 350():h717. PubMed ID: 25663035
    [No Abstract]   [Full Text] [Related]  

  • 48. VOICE reveals the need to improve adherence in PrEP trials.
    Tobin SC
    AIDS; 2015 Jul; 29(12):N9. PubMed ID: 26244400
    [No Abstract]   [Full Text] [Related]  

  • 49. AIDS research. Microbicide fails to protect against HIV.
    Cohen J
    Science; 2008 Feb; 319(5866):1026-7. PubMed ID: 18292313
    [No Abstract]   [Full Text] [Related]  

  • 50. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
    Vibholm L; Reinert LS; Søgaard OS; Paludan SR; Østergaard L; Tolstrup M; Melchjorsen J
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Preexposure prophylaxis for HIV infection--current data and recommendations].
    Kümmerle T; Fätkenheuer G
    Dtsch Med Wochenschr; 2012 Nov; 137(44):2285-8. PubMed ID: 23093400
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti HIV gel shows no promise in clinical trial.
    AORN J; 2009 Apr; 89(4):748. PubMed ID: 19434949
    [No Abstract]   [Full Text] [Related]  

  • 54. Preexposure prophylaxis reduces HIV risk in injection-drug users.
    Rosenberg K
    Am J Nurs; 2013 Sep; 113(9):17. PubMed ID: 23985594
    [No Abstract]   [Full Text] [Related]  

  • 55. A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
    Bauermeister JA; Golinkoff JM; Carballo-Diéguez A; Giguere R; López D; Hoesley CJ; Chen BA; Anderson P; Dezzutti CS; Strizki J; Sprinkle C; Heard F; Hall W; Jacobson C; Berthiaume J; Mayo A; Richardson BA; Piper J;
    AIDS Behav; 2020 Feb; 24(2):607-616. PubMed ID: 30877580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV microbicide trials halted.
    Wakabi W
    CMAJ; 2007 May; 176(11):1569-70. PubMed ID: 17515576
    [No Abstract]   [Full Text] [Related]  

  • 57. Microbicides may be ready.
    AIDS Patient Care STDS; 2002 May; 16(5):243. PubMed ID: 12055033
    [No Abstract]   [Full Text] [Related]  

  • 58. Changes in condom use during a microbicide clinical trial in Pune, India.
    Marlow HM; Tolley EE; Weaver MA; Kohli R; Mehendale S
    AIDS Care; 2012; 24(5):539-43. PubMed ID: 22088145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential of vaginal microbicides in HIV control.
    Stone A
    J R Soc Med; 2004 Mar; 97(3):158. PubMed ID: 14996989
    [No Abstract]   [Full Text] [Related]  

  • 60. Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently: response to Smith et al. (2005).
    Foss AM; Watts CH; Vickerman PT; Heise L
    AIDS; 2006 Jan; 20(2):303-5. PubMed ID: 16511432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.